Advised a consortium comprised of QIC, Chinese investment fund Pagoda and Goldman Sachs’ private equity arm on various tax issues associated with its successful bid to acquire a majority stake in the Icon Cancer Care Group which operates a vertically integrated cancer care business in Australia and Singapore.
This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.